Compare BAER & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAER | IKT |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.3M | 201.3M |
| IPO Year | N/A | 2020 |
| Metric | BAER | IKT |
|---|---|---|
| Price | $2.68 | $1.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $5.25 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.1M | 673.2K |
| Earning Date | 03-12-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $129,868,000.00 | N/A |
| Revenue This Year | $24.95 | N/A |
| Revenue Next Year | $10.18 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 54.35 | N/A |
| 52 Week Low | $1.02 | $1.33 |
| 52 Week High | $3.44 | $3.32 |
| Indicator | BAER | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 49.80 | 49.06 |
| Support Level | $2.68 | $1.57 |
| Resistance Level | $3.03 | $1.72 |
| Average True Range (ATR) | 0.31 | 0.09 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 22.21 | 57.41 |
Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF (Super Scooper) aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.